Salt Lake City, UT, United States of America

Richard S Smith


Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Del Mar, CA (US) (2003 - 2006)
  • Salt Lake City, UT (US) (2008 - 2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Richard S. Smith

Introduction

Richard S. Smith is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of immunology, particularly in relation to the Epstein-Barr virus (EBV). With a total of 4 patents, his work has implications for the diagnosis and treatment of EBV-associated diseases.

Latest Patents

Among his latest patents are several immunoreactive peptides derived from the Epstein-Barr virus. These specific polypeptides include ETFTETWNRFITHTE (SEQ. ID NO: 1), GMLEASEGLDGWIHQ (SEQ. ID NO: 2), HQQGGWSTLIEDNIP (SEQ. ID NO: 3), and KQKHPKKVKQAFNPL (SEQ. ID NO: 4). The patents disclose the use of these polypeptides for the production of polypeptide-specific antibodies, which can be utilized in the diagnosis and treatment of diseases associated with EBV.

Career Highlights

Richard S. Smith has had a distinguished career, working with reputable organizations such as Ortho Diagnostic Systems Inc. and Georgetown University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Throughout his career, Richard has collaborated with notable colleagues, including D. Elliot Parks and Gary R. Pearson. These collaborations have further enriched his research and innovation efforts.

Conclusion

Richard S. Smith's contributions to the field of immunology, particularly regarding the Epstein-Barr virus, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…